LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

DIESSE Diagnostica Demonstrates Advanced Immunoassay and ESR Analyzers at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 12 Apr 2022
Print article
Image: The CHORUS TRIO and VES MATIC 5 presented at EUROMEDLAB (Photo courtesy of Diesse Diagnostica)
Image: The CHORUS TRIO and VES MATIC 5 presented at EUROMEDLAB (Photo courtesy of Diesse Diagnostica)

Diesse Diagnostica Senese S.p.A. (Rigoni, Italy) demonstrated its CHORUS TRIO and VES MATIC 5 instruments at EUROMEDLAB 2022 which was held 10th-14th April 2022 in Munich, Germany.

CHORUS TRIO is an easy-to-use single test multiparametric system for immunometric assay. The single test device contains all the reagents necessary to perform the assay, thus eliminating hidden costs or waste of reagents. Ease of use and the most expansive selection of tests available on the market (infectious diseases, autoimmunity, endocrinology, and tumor markers, allergy, bone metabolism, inflammation) make it the ideal tool for performing small series diagnostic tests while ensuring maximum flexibility in organizing the clinical laboratory’s workflow. From the smallest to the largest, CHORUS TRIO easily adapts to the needs of any clinical analysis laboratory.

At EUROMEDLAB 2022, Diesse Diagnostica also demonstrated its new VES MATIC 5 automatic instrument for the determination of the ESR directly on the hematocrit tube (190 samples/hour), using racks from the main cell counters. ESR is a valuable laboratory test in a range of clinical conditions, such as rheumatoid diseases, orthopedic infections and Hodgkin’s lymphoma, and it can be used for the follow‐up of infectious, inflammatory, malignant and autoimmune diseases. Featuring IoT with internal cameras for advanced remote assistance, along with a modern and interactive graphic user interface, VES MATIC 5 offers continuous and random access loading of any kind of cell counter racks. Diesse Diagnostica plans to soon enable VES MATIC 5 to provide artificial intelligence-based recognition of lipemic, hemolyzed, coagulated and mislabeled samples.

Related Links:
Diesse Diagnostica Senese Spa 

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
Coagulation Analyzer
CS-2400

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.